Intertek acquires US-based QTI

UK's Intertek Group, a scientific services company, has acquired Quantitative Technologies Inc (QTI). QTI will operate in the Intertek pharmaceutical services group.

UK's Intertek Group, a scientific services company, has acquired Quantitative Technologies Inc (QTI). QTI will operate in the Intertek pharmaceutical services group.

QTI is a contract analytical research and development laboratory that specialises in the pre-market launch stages of the drug and product development life cycle. The firm is located in New Jersey, US, with approximately 60 staff and counts major global pharmaceutical companies among its clients.

The acquisition advances Intertek's strategic growth in expert support services to the global pharmaceutical, medical device and drug delivery industry through the provision of state of the art analytical services.

Intertek's Mark Loughead said: 'QTI has an outstanding reputation in the industry and will further expand our ability to support the pharmaceutical and related sectors for outsourced r&d and testing expertise.'

John Conti-Ramsden, global director for Intertek pharmaceutical services, added: 'The acquisition of QTI further develops Intertek's US offering and global platform in the area of pharmaceutical services.'